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Abstract
Background. The optimal treatment of gallstones with 
associated common bile duct stones in the laparoscopic 
era is controversial. Various reviews and decision based 
algorithms have been published, but the superior 
treatment modality is unclear. Therefore, a meta-
analysis was conducted to compare the two most 
commonly used treatment strategies.
Methods. A systematic review was conducted to 
compare single stage laparoscopic cholecystectomy 
with common bile duct exploration versus a combined 
endoscopic and laparoscopic treatment. Eligible 
studies were identified using a search of Medline, 
Embase, Cochrane and Science Citation Index 
Expanded databases. Appropriately selected articles 
were independently reviewed and data was extracted 
and cross referenced. A meta-analysis was conducted 
of the pooled trial data to determine difference in 
outcomes.
Results. A total of seven randomized trials were 
identified with 746 patients with 366 in the laparoscopic 
only treatment group and 380 in the combined 
endoscopic and laparoscopic treatment arms. There 
was no significant difference in successful bile duct 
clearance between the two groups (OR 1.23; 95% CI 
0.55 to 2.75, P = 0.61). There was no statistical difference 
in morbidity (RR 1.23; 95% CI 0.92 to 1.66; P = 0.17), 
mortality (RD -0.00; 95% CI -0.02 to 0.01, P = 0.59) or 
length of hospital stay (MD -0.31; 95% CI -1.68 to 1.06, P 
= 0.66). However, there was a statistically significant 
difference in the duration of procedure in favour of the 
single stage laparoscopic treatment (MD -6.83; 95% CI 
-9.59 to -4.07, P < 0.00001).
Conclusion. Both the laparoscopic alone or the combi-
ned endoscopic and laparoscopic treatment approa-
ches show comparative efficacy in management of 
symptomatic gallstones with associated choledocholi-
thiasis.    
Keywords
gallstones, choledocholithiasis, cholecystectomy, lapa-
roscopic, endoscopic retrograde cholangiopancreato-
graphy
Sažetak
Pozadina. Optimalno liječenje žučnih kamenaca uz 
prateće žučne kamence u glavnom žučovodu u eri 
laparoskopske kirurgije je kontroverzno. Objavljeni su 
razni pregledni radovi i algoritmi odlučivanja, no 
pitanje odluke o odabiru preporučenog načina liječenja 
ostaje neriješeno. S ciljem usporedbe dva najčešće 
korištena načina liječenja provedena je meta-analiza.
Metode. Sistematsko istraživanje provedeno je kako bi 
se usporedila kolecistektomija s eksploracijom glavnog 
žučovoda u jednom aktu u odnosu na kombinirano 
endoskopsko i laparoskopsko liječenje. Dostupne 
studije nađene su pomoću sljedećih baza podataka: 
Medline, Embase, Cochrane i Science Citation Index 
Expanded. Probrani relevantni radovi zasebno su 
pregledani, a podaci izdvojeni i međusobno 
uspoređeni. Provedena je meta-analiza svih 
prikupljenih podataka da bi se odredila razlika u 
ishodima.
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META-ANALYSIS OF THE EFFICACY OF A SINGLE-STAGE 
LAPAROSCOPIC MANAGEMENT VERSUS TWO-STAGE ENDOSCOPIC 
MANAGEMENT OF SYMPTOMATIC GALLSTONES WITH COMMON 
BILE DUCT STONES
Meta-analiza učinkovitosti laparaskopskog liječenja u jednom aktu u 
usporedbi s endoskopskim liječenjem simptomatskih žučnih 
kamenaca i žučnih kamenaca u glavnom žučovodu u više akata 
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Rezultati. Pronađeno je sveukupno sedam 
randomiziranih studija sa 746 pacijenata od kojih je 
366 u skupini liječenoj isključivo laparoskopski te 380 
liječenih kombinirano endoskopski i laparoskopski. 
Nije utvrđena značajna razlika u uspješnom čišćenju 
žučnih vodova između dvije skupine (OR 1,23; 95% CI 
0,55 do 2,75, P = 0,61). Nije nađena značajna razlika u 
morbiditetu (RR 1,23; 95% CI 0,92 do 1,66; P = 0,17), 
smrtnosti (RD -0,00; 95% CI -0.02 do 0,01, P = 0,59) ili 
trajanju hospitalizacije (MD -0,31; 95% CI -1,68 to 1,06, 
P = 0,66). Međutim, postojala je statistički značajna 
razlika u trajanju zahvata (MD -6,83; 95% CI -9,59 do 
-4,07, P < 0,00001).
Zaključak. Laparoskopski ili kombinirani endoskopski i 
laparoskopski pristup liječenju pokazuje značajnu 
učinkovitost u liječenju simptomatskih žučnih 
kamenaca s pratećom koledoholitijazom.
Ključne riječi
žučni kamenci, koledoholitijaza, kolecistektomija, la-
paroskopski, endoskopska retrogradna kolangiopank-
reatografija
1. Introduction
Cholelithiasis and complications thereof are a common 
clinical entity as 5 to 25% of adults in western countries 
have gallstones [1]. Symptoms and complications 
related to gallstones are one of the most costly 
digestive disorders [2]. In addition, 10-15% of patients 
with gallstones have associated or suspected common 
bile duct (CBD) stones (choledocholithiasis) [3, 4] and 
several risk factors, including clinical, biochemical and 
imaging variables, can help predict the presence of 
CBD stones [4]. 
Endoscopic retrograde cholangiopancreatography 
(ERCP) combined with endoscopic sphincterotomy (ES) 
has a key role in the management of CBD stones. 
Successful clearance of CBD stones ranges between 87 
to 97% depending on the experience of the endoscopist 
[5, 6]. ERCP has evolved from a diagnostic to a 
therapeutic procedure due to high rate of negative 
examinations, risk of complications and increasing 
availability of laparoscopic common bile duct 
exploration (LCDBE) [7, 8]. Other non-invasive or 
minimally invasive diagnostic techniques to detect 
CBD stones have also evolved [9-11], and it is therefore 
imperative to identify the most efficient and effective 
treatment strategy for CBD stones. Laparoscopic 
cholecystectomy (LC) has replaced open 
cholecystectomy as the standard treatment for 
gallbladder stones [12, 13], with successful common 
bile duct clearance rates in experienced hands 
exceeding 90% [3, 14, 15]. Therefore, with improved 
skill and advances in laparoscopic techniques and 
given the time frame of previous reviews, a comparison 
of the two approaches is essential to identify the most 
optimum method of treatment of symptomatic 
gallstones with associated CBD stones.
 2. Materials and Methods
2.1. Study design
This review was conducted according to the PRISMA 
guidelines for systematic review reporting [16]. A 
quality assessment of each trial using the Cochrane 
collaboration tool for assessing the risk of bias was 
applied [17]. The design is a systematic review with 
meta-analysis of randomized controlled trials with no 
restriction on the year of publication, or language.
2.2. Inclusion and exclusion criteria
We included in this review randomized controlled trials 
comparing single stage laparoscopic exploration of 
CBD with LC to a two stage endoscopic with LC 
treatment irrespective of language, year of publication 
or patient populations in the primary studies. We 
excluded observational studies, review articles and 
other non-randomized trials comparing both 
interventions. Outcomes measured include; primary 
outcome - successful bile duct clearance of stones, 
secondary outcomes include - morbidity, mortality, 
length of hospital stay, duration of procedure and total 
hospital cost.
2.3. Search methods for identification of studies
The electronic data base searched till March 2012 
includes The Cochrane Hepato-Biliary Group Controlled 
trials Register, Cochrane Central Register of Controlled 
Trials in the Cochrane Library, Medline (1950 to March 
2012), Embase (1980 to March 2012), and Science 
citation index expanded database (1970 to March 
2012). The following keywords: gallstones OR 
choledocholithiasis OR (“bile duct stones” 
AND  cholecystectomy); laparoscopic OR choledo-
chotomy; laparoscopic OR (laparoscopic AND “bile 
duct”) AND (cholangiopancreatography endosco pic 
retrograde OR endoscopic sphincterotomy). These 
keywords were mapped to Medline medical subject 
heading (MeSH) terms as well as searched for as text 
items. A filter for identification of randomized 
controlled trials recommended by the Cochrane 
Collaboration was used to filter out non-randomized 
trials in Medline and Embase database. Hand searches 
of references of cited journals were conducted to also 
identify potential eligible articles to include in the 
review. Search of reputable international conference 
journals was also conducted to identify potential 
eligible papers.
2.4. Study selection and data extraction
A flow sheet was used to tract abstracts of identified, 
screened and eligible articles (Figure 1). Full text of 
eligible articles was  independently reviewed by two 
investigators and required data of the outcomes 
needed to collate results was collected by two 
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independent investigators on a data extraction sheet. 
This is further synthesized into a comprehensive 
summary of randomized trials table comparing both 
treatment outcomes as shown in Table 1. For missing 
outcome data, a contact was made with the 
corresponding author by e-mail to obtain such 
additional information.
2.5. Quality assessment of included studies
There is a risk of over or under estimation of beneficial 
treatment effects in trials with high risks of bias [17]. 
Selected trials were graded for risk of bias at study level 
using the guidelines of the Cochrane collaboration tool 
for assessing risk of bias table and quality assessment 
[18]. The assessment was done on trials using the six 
main components of the tool such as; sequence 
generation, allocation concealment, blinding of 
participant, personnel and outcome assessors, 
incomplete outcome data, selective outcome reporting 
and other sources of bias such as funding bias or early 
stopping bias. A score was given to each component of 
either “low risk”, “unclear” or “high risk”, and reasons for 
the score are included (Table 2). Three of the trials show 
low risk of bias in the parameters while the remaining 
studies are low risk in two parameters. The performance 
and detection bias were of high risk as there was no 
attempt of blinding in any trials though the outcomes 
are objectively measured but the impact on the results 
and trials quality may be difficult to predict.
2.6. Statistical methods
The software package Review Manager 5 [19] provided 
by the Cochrane Collaboration Version 5.1 
(Copenhagen) was used for data analysis. For 
dichotomous outcomes, odds ratio or relative risk with 
95% confidence interval was calculated using the 
Mantel-Haenszel statistical method for the meta-
analysis. For data with zero events, risk difference was 
calculated; this was used for the mortality results. While 
for continuous outcomes, the mean difference with 
95% confidence interval was used. In continuous 
outcomes, if mean and standard deviation were not 
given, the median and range can be used to estimate 
the mean and variance using the formula proposed by 
Hozo et al. [20], and the estimated result will be used 
for the meta-analysis.
For odds ratio and mean difference outcomes, we used 
the random-effects and fixed-effect models (e.g. see 
Figure 2). If there are no differences between the results 
of the two models, the fixed effect model will be 
reported. If differences exist in the intervention effects, 
both the random and fixed effect model will be 
reported, otherwise the random effect model will be 
reported if statistical heterogeneity exists.
Heterogeneity was explored using the chi-squared 
test, to provide an indication for between-study 
heterogeneity with a significance set at P < 0.050. The 
degree of heterogeneity observed in the results was 
quantified using the I-squared (I2) statistics, which is 
presented as a percentage, with heterogeneity 
considered not to be present within a range of 0-50%. 
On finding significant heterogeneity in the result, a 
careful review of the studies will be conducted to 
identify the reason for this.
A funnel plot of the primary outcome was determined 
to look for potential publication bias in the trials (Figure 
3). Data analysis was based on the results obtained 
according to the "intention-to-treat" principle in each 
original study, using the fixed or random effects model 
for meta-analysis.
3. Results
3.1. Results of the literature search
A total of 884 articles were identified through searches 
of electronic journal databases, with no additional 
article identified through hand searches of references 
of published articles. Following exclusions of duplicates, 
843 articles were screened by the investigative team. 
Abstracts of screened papers were retrieved and a total 
of 11 full text articles were obtained. The texts were 
further screened and only seven [21-27] articles meet 
the inclusion criteria of the present review comparing 
laparoscopic single stage treatment to endoscopic 
two-stage treatment of common bile duct and gall 
bladder stones. A total of 746 patients randomised 
between LC and LCBDE versus ERCP/ES and LC. Figure 1 
shows the flow chart for selection of articles according 
to the Preferred Reporting Items for Systematic reviews 
and Meta-Analysis. A summary of RCT of included 
studies with summary results of the outcomes are 
shown in Table 1.
3.2. Description of included trials
Distribution of patients between either treatment arms 
is fairly even with 366 patients in the laparoscopic and 
380 in the endoscopic treatment arms. Five trials [22-
25, 27] compared LCBDE versus pre-operative ERCP + 
LC, while two trials [21, 26] compared LCBDE versus LC 
with post-operative ERCP. Most of the endoscopic two-
stage treatment performed the LC during same 
admission, except one trial [27] that performed LC 4-6 
weeks post ERCP. Follow up duration was mentioned in 
two trials [22, 24] while a trial [26] gives some long term 
complications without specifying follow-up duration. 
Sample size calculation was explained in three trials 
[23, 25, 26], while it was not clear how it was done in 
another trial [21].   
All trials were performed on fit adult population from 
age 18 and above with ASA grade I and II with fitness 
for general anaesthesia except one trial [23] that 
recruits elderly patients with average age of 74 years 
with co-morbidities and ASA grade I to III. Sex 
distribution is equivalent across most trials. Only two 
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trials [25, 26] are multi-institutional, while the remaining 
a single institution. Three trials had confirmed CBD 
stones before randomization, one trial [27] was by 
MRCP/EUS, while the remaining two trials [21, 24] were 
by intraoperative cholangiography and had intra-
operative randomization. Exclusion criteria were 
uniform in most studies, although some trials stated 
the reason for exclusion. Interventions performed were 
explained in all the trials except some few differences, 
one trial [24] performed only trancystic approach, 
while another trial [27] performed only the 
choledochotomy approach. The primary outcome is 
given in all trials, including data for morbidity, mortality 
and length of hospital stay. Duration of procedure is 
only reported in four trials, while total cost of 
hospitalisation was reported by one trial [24].
3.3. Quality assessment of included studies
The quality assessment of included studies is 
summarized in Table 2. Three of the trials show low risk 
of bias in the parameters while the remaining has low 
risk in two parameters. The performance and detection 
bias were of high risk as there was no attempt of 
blinding in any trials though the outcomes are 
objectively measured but the impact on the results and 
trials quality may be difficult to predict.
3.4. Effects of interventions
Primary outcome: successful ductal clearance
A total of 746 patients were randomized, 366 in the 
laparoscopic treatment and 380 in the endoscopic 
treatment arm. A total of 259 patients had successful 
ductal stones clearance against 254 patients in the 
endoscopic arm, giving a rate of 70.8% and 66.8% 
respectively, on an intention-to-treat basis. Our meta-
analysis found no statistical difference between the 
treatment arms as shown in the forest plot with OR of 
1.23 95% CI 0.55 to 2.75, p=0.61 and I2 =71% using the 
random effects model due to statistical heterogeneity 
(Figure 2). The funnel plot for the studies in relation to 
the primary outcome on Figure 3 shows that only two 
out of the seven trials are outside the triangle thus 
indicating a lack of or at least a very low degree of 
publications bias.
Morbidity
The total morbidity rate was 20.2% in the laparoscopic 
arm and 16.6% in the endoscopic treatment, relative 
risk 1.23, 95% CI 0.92 to 1.66, P=0.17 and I2=0%, using 
the fixed effect model. The forest plot on Figure 4 shows 
no statistical difference between the treatment arms.
Mortality
There were two deaths in the laparoscopic treatment 
and four in the endoscopic treatment arms, with no 
statistically significant difference between them. Risk 
difference of -0.0 and 95% CI -0.02, 0.01 and the forest 
plot using fixed effect model due to lack of 
heterogeneity are shown on Figure 5. 
Length of hospital stay
All the trials reported the total length of hospital stay in 
median and range and the meta-analysis was 
performed by converting these data to mean and SD 
values. The results show no statistical difference 
between treatment arms with mean difference of -0.29, 
CI of -1.68-1.10 and P = 0.68 with a random effects 
model (Figure 6). One of the trials has provided 
inadequate data but the contact with the author for 
missing data by e-mail has not returned any additional 
information.
It is important to note that five of the studies show a 
shorter length of hospital stay in the single-stage 
laparoscopic treatment arm and the difference ranges 
between one and three days with statistical significance 
in two of the trials [21, 25], with a significant difference 
also between the trancystic approach to the endoscopic 
treatment in one study [22]. Though, one of the trials 
[26] is not included in the meta-analysis due to 
incomplete reporting, there is a low probability of 
tipping the overall result in favour of the single-stage 
treatment if this study had been included. Only one 
trial shows a shorter stay with endoscopic treatment 
[23] while one trial shows no differences in length of 
stay [27].
Duration of procedure
Only four trials reported on duration of procedure, data 
were presented in median and range, except in the 
study by Rogers et al. [24] that reported mean and SD. 
The meta-analysis was done with only three trials due 
to inadequate data in the fourth trial, though an e-mail 
request was sent to the author for the missing outcome 
data.
The results from the meta-analysis (Figure 7) show a 
statistical significance in favour of the single stage 
laparoscopic treatment as shorter in duration of 
procedure compared to the two-stage endoscopic 
treatment with P < 0.00001, CI -9.59 to -4.07. It is also 
important to note that, overall, only three of the trials 
reported a shorter duration of procedure in the single-
stage treatment (median values) and the differences 
range from 15 to 18 min, with no statistical significance. 
Only one trial [26] reported a longer duration in the 
two-stage treatment arm but it was not included in the 
meta-analysis due to inadequate data.
Health economics
Only the study by Rogers et al. [24] reported the total 
hospital charges with a median of $24,399 (range 
11,190-60,138) in the single stage treatment to $26,656 
(range 4,496-85,085) in the two stages endoscopic 
treatment. The study found, however, a statistically 
significant difference in the professional fees between 
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the single stage treatment with mean (SD) of $5054 
(1637) against two stage treatment with a mean of 
$6191(1583) (P = 0.001).
4. Discussion
This systematic review and meta-analysis of randomized 
controlled trials include seven studies containing 746 
patients into either laparoscopic single stage treatment 
or to endoscopic two-stage treatment arm. The results 
demonstrate equivalent success in common bile duct 
stone clearance rate, morbidity, mortality and length of 
hospital stay, but a statistically significant difference in 
favour of the single stage technique in terms of 
duration of procedure. The first review on this subject 
by Tranter et al. [28] in 2002 involved two randomized 
controlled trials (RCTs) and reported similar clearance 
rates and length of stay between laparoscopic surgery 
and endoscopic treatment, but higher morbidity and 
mortality in the endoscopic treatment. In addition, 
Martin et al. [29] in a Cochrane review with 591 patients 
in five RCTs found no significant difference in mortality, 
morbidity, treatment success and procedure time. 
Length of stay was reported shorter in three trials but 
not subjected to analysis. Clayton et al. [30] found 
similar outcomes in the combined endoscopic and 
laparoscopic treatment. A recent review by Alexakis et 
al. [31] though currently in abstract form, suggests 
equivalent outcomes between single stage and two-
stage management of CBD stones.
Various treatment algorithms have been developed 
regarding the management of gallstones with 
associated CBD stones [32]. It is pertinent to note that 
choledocholithiasis could be discovered before, during 
or after cholecystectomy. Our review on an intention-
to-treat basis shows clearance rate of 71% in the 
laparoscopic treatment group compared to 69% in the 
endoscopic treatment cohort. On further analysis 
according to the actual rate of stone clearance, there is 
improvement in clearance rates of 87.5% to 86% 
between the laparoscopic to endoscopic treatment 
respectively. This compares favourably with various 
consecutive series of efficacy in the treatment of CBD 
stones that report bile duct clearance rates in the 
laparoscopic single treatment ranging from 85% to 
95% and 87% to 97% in the endoscopic group [5, 6]. 
Interestingly, only one study in our review shows a 
statistical significance of laparoscopic clearance over 
the endoscopic clearance [23]. 
The endoscopic management of choledocholithiasis 
has a relatively low failure rate, however it has the 
advantage that it can be repeated multiple times and 
requires only sedation rather than general anaesthesia. 
Also delaying stone clearance should not delay gall 
bladder surgery as a stent could be utilised in the short-
term period. This is supported by a RCT by Chang et al. 
[33] which demonstrated no superior outcome in pre- 
versus post-operative endoscopic management of 
choledocholithiasis.
Mortality in either treatment arms is less than 1%, 
which is consistent with the literature and also with 
previous reviews. Our review shows a morbidity rate of 
20% to 16.5% in the laparoscopic and endoscopic 
treatment respectively. Since the LCBDE was first 
reported in early 90’s, long term reviews of this 
procedure have now been reported. Waage et al. [34] 
conducted a long term review of 152 patients over a 
period of 6-72 months and also, a review by Andrew et 
al. [35] of 116 patients over 63 months, both 
demonstrate no long term biliary tract complications 
apart from small recurrence of CBD stones. This is 
similar to a study by Tranter et al. that reviewed medium 
to long term complications of ERCP/ES and reported 
recurrent CBD stone rate of 2-16%, cholangitis 1-6%, 
and potential risk of biliary tract cancer due to 
destruction of the sphincter of Oddi [28]. 
Cost is an important variable in health care decision 
making processes, and only one study compared cost 
between the two treatment strategies. This study 
reported a statistical significance in favour of the single 
stage treatment in regard to professional fees. Some 
observational studies have evaluated this variable in 
determining the optimum modality of treatment. Topal 
et al. [36] reported a consecutive series of 53 cases and 
demonstrated a reduction in favour of hospital cost for 
single stage treatment. Other studies examining 
healthcare costs have used different methodologies to 
analyse this parameter, and the conclusions are mixed 
[37-39]. Some important factors affecting hospital cost 
are; length of hospital stay, cost of operating theatre 
and professional fees. In this review there was no 
statistical difference in length of hospital stay, however 
two studies reported a statistical significance in this 
variable of between 2-3 days difference. 
A limitation of this meta-analysis is that it included 
mostly patients who were low anaesthetic risk with 
ASA grades I and II, and an age range of 18-89 years. 
The exception is the study by Noble et al. [23] that 
specifically examined higher risk patients (elderly 
patients with co-morbidities and ASA grade I-III). 
Therefore a limitation of this study is that the findings 
may not be applicable to elderly patients with 
significant competing medical co-morbidities 
presenting with choledocholithiasis. 
Further limitations of this meta-analysis are that none 
of the studies address the issue of performance and 
detection bias, but since the outcomes in the review 
are objectively measured, its impact on the intervention 
effects maybe relative. Though sample size calculation 
was done in three studies, this review by pooling 
together data has increased the power of previous 
published research where a clear conclusion was not 
possible. The population of patients in this review is still 
small for a common disease that affects millions of 
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people. The qualities of the continuous variable data 
are mostly non-parametric and our calculations to 
parametric data may be prone to errors and may affect 
the meta-analysis.
In conclusion, this meta-analysis demonstrates an 
equivalent comparison between laparoscopic and 
endoscopic treatment of common bile duct stones in 
terms of bile duct clearance rates, morbidity, mortality 
and length of hospital stay, but a difference in duration 
of the procedure. These results should be helpful to 
appropriately inform patients regarding the risks, 
benefits and alternative treatment strategies of this 
clinical entity.
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Figure 1. Number of articles identified and screened in the systematic review.
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Figure 2. Forest plot of odds ratio of successful ductal stones clearance in 
LC + LCBDE vs ERCP/ES + LC.
Figure 3. Funnel plot, illustrating the lack of publication bias.
Figure 4. Forest plot of total post-operative morbidity b/w 
LC + LCBDE versus ERCP/ES + LC.
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Figure 5. Forest plot of post-operative mortality b/w LC + LCBDE Versus ERCP/ES + LC.
Figure 6. Forest plot of the length of hospital stay b/w  LC + LCBDE Versus ERCP/ES +LC.
Figure 7. Forest plot of the duration of procedure b/w LC + LCBDE Versus ERCP/ES + LC.
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Table 1. Summary of randomized trials comparing laparoscopic against endoscopic clearance of common bile duct stones.
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Bansal 2010
Laparoscopic 15 47.1 4:11 14 4 0 4.2a n/a
Endoscopic 15 39.1 5:10 13 4 0 4a n/a
Rogers
2010
Laparoscopic 57 39.9 17:40 15 6 0 4 160
Endoscopic 55 44.6 16:39 30 5 0 5 178
Noble
2009
Laparoscopic 44 75.9 16:28 44 19 0 5 n/a
Endoscopic 47 74.3 22:25 26 14 1 3 n/a
Nathanson
2005
Laparoscopic 41 56.1 16:25 40 12 0 6.4 158.8
Endoscopic 45 59.6 17:28 43 11 0 7.7 147.9
Sgourakis
2002
Laparoscopic 36 43-88 15:21 24 5 1 7.4 90
Endoscopic 42 46-89 17:25 27 6 1 9 105
Cuschieri
1999
Laparoscopic 133 19-88 6:9 92 21 1 6 n/a
Endoscopic 136 18-89 7:18 82 17 2 9 n/a
Rhodes
1999
Laparoscopic 40 62 12:28 30 7 0 1 90
Endoscopic 40 68 14:26 30 6 0 3.5 105
Total
Laparoscopic 366 259(70.8%) 74 2
Endoscopic 380 254(66.8%) 63 4
(a)  Value in mean
Table 2.  Quality check of all trials.
Reference Sequence generation
Allocation 
concealment
Blinding of 
participants 
and personnel
Blinding of 
outcome 
assessment
Incomplete 
outcome data 
Selective 
outcome 
reporting
Bansal et al + ? - - + +
Cuschieri et la + + - - ? +
Nathanson et al + + - - + ?
Noble et al + ? - - ? +
Rhodes et al ? - - - + +
Rogers et al ? + - - ? +
Sgourakis et al ? - - - + +
Note: (?) Unclear risk of bias; (-) high risk of bias; (+) low risk of bias.
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